Neuropathic pain: Diagnosis, pathophysiological mechanisms, and treatment

The Lancet Neurology

Volumn 9, Issue 8, 2010, Pages 807-819

  Baron, Ralf ^a   Binder, Andreas ^a   Wasner, Gunnar ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; CAPSAICIN; CARBAMAZEPINE; DESIPRAMINE; DULOXETINE; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; LEVORPHANOL; LIDOCAINE; METHADONE; MORPHINE; NORTRIPTYLINE; OMEGA CONOTOXIN MVIIA; OXCARBAZEPINE; OXYCODONE; PREGABALIN; TETRAHYDROCANNABINOL; TOPIRAMATE; TRAMADOL; VALPROIC ACID; VENLAFAXINE;

APPLICATION SITE ERYTHEMA; APPLICATION SITE RASH; BODY WEIGHT; CANCER PAIN; CARDIOTOXICITY; CLINICAL FEATURE; CONSTIPATION; DIABETIC NEUROPATHY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERABILITY; ELDERLY CARE; EPIDURAL ANESTHESIA; GLAUCOMA; HUMAN; KIDNEY DISEASE; NAUSEA; NEUROPATHIC PAIN; NONHUMAN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PERIPHERAL EDEMA; PERIPHERAL NERVE INJURY; POLYNEUROPATHY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; SEDATION; SEIZURE; SEROTONIN SYNDROME; SIDE EFFECT; SPINAL CORD STIMULATION; SUICIDAL IDEATION; SYMPATHETIC BLOCKING; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT DURATION; TREATMENT INDICATION; TRIGEMINUS NEURALGIA; URINE RETENTION; VACCINATION; VOMITING; WITHDRAWAL SYNDROME; XEROSTOMIA;

HUMANS; NEURALGIA; PAIN; PAIN MEASUREMENT; POLYNEUROPATHIES; TREATMENT OUTCOME;

EID: 77955326429     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70143-5     Document Type: Review

References (89)

1. Baron R Mechanisms of disease: neuropathic pain-a clinical perspective. Nat Clin Pract Neurol 2006, 2:95-106.
2. Baron R Neuropathic pain: clinical. The Senses: a Comprehensive Reference 2008, vol 5:865-900. Elsevier, Amsterdam. A.I. Basbaum, A. Kaneko, G.M. Shepherd (Eds.).
3. Cruccu G, Sommer C, Anand P, et al. EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol 2010, published online March 8. 10.1111/j.1468-1331.2010.02969.
4. Maier C, Baron R, Toelle T, et al. Quantitative Sensory Testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain 2010, published online June 7. 10.1016/j.pain.2010.05.002.
5. Greenspan JD, Ohara S, Sarlani E, Lenz FA Allodynia in patients with post-stroke central pain (CPSP) studied by statistical quantitative sensory testing within individuals. Pain 2004, 109:357-366.
6. Bennett MI, Attal N, Backonja MM, et al. Using screening tools to identify neuropathic pain. Pain 2007, 127:199-203.
7. Bouhassira D, Attal N, Fermanian J, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004, 108:248-257.
8. Haanpaa ML, Backonja MM, Bennett MI, et al. Assessment of neuropathic pain in primary care. Am J Med 2009, 122:S13-S21.
9. Rasmussen PV, Sindrup SH, Jensen TS, Bach FW Symptoms and signs in patients with suspected neuropathic pain. Pain 2004, 110:461-469.
10. Costigan M, Scholz J, Woolf CJ Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009, 32:1-32.
11. Woolf CJ, Bennett GJ, Doherty M, et al. Towards a mechanism-based classification of pain?. Pain 1998, 77:227-229.
12. Wasner G, Kleinert A, Binder A, Schattschneider J, Baron R Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin. J Neurol 2005, 252:677-686.
13. Attal N, Rouaud J, Brasseur L, Chauvin M, Bouhassira D Systemic lidocaine. Neurology 2004, 62:218-225.
14. Finnerup NB, Biering-Sorensen F, Johannesen IL, et al. Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial. Anaesthesiology 2005, 102:1023-1030.
15. Herrmann DN, Pannoni V, Barbano RL, Pennella-Vaughan J, Dworkin RH Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies. Muscle Nerve 2006, 33:42-48.
16. Scholz J, Mannion RJ, Hord DE, et al. A novel tool for the assessment of pain: validation in low back pain. PLoS Med 2009, 6:e1000047.
17. Wasner G, Baron R Pain: clinical pain assessment: from bedside to better treatment. Nat Rev Neurol 2009, 5:359-361.
18. Nystrom B, Hagbarth KE Microelectrode recordings from transected nerves in amputees with phantom limb pain. Neurosci Lett 1981, 27:211-216.
19. Orstavik K, Namer B, Schmidt R, Schmelz M, Hilliges M, Weidner C Abnormal function of C-fibers in patients with diabetic neuropathy. J Neurosci 2006, 26:11287-11294.
20. Orstavik K, Jorum E Microneurographic findings of relevance to pain in patients with erythromelalgia and patients with diabetic neuropathy. Neurosci Lett 2010, 470:108-204.
21. Amir R, Kocsis JD, Devor M Multiple interacting sites of ectopic spike electrogenesis in primary sensory neurons. J Neurosci 2005, 25:2576-2585.
22. Wu G, Ringkamp M, Murinson BB, et al. Degeneration of myelinated efferent fibers induces spontaneous activity in uninjured C-fiber afferents. J Neurosci 2002, 22:7746-7753.
23. Bostock H, Campero M, Serra J, Ochoa JL Temperature-dependent double spikes in C-nociceptors of neuropathic pain patients. Brain 2005, 128:2154-2163.
24. Lai J, Hunter JC, Porreca F The role of voltage-gated sodium channels in neuropathic pain. Curr Opin Neurobiol 2003, 13:291-297.
25. Black JA, Nikolajsen L, Kroner K, Jensen TS, Waxman SG Multiple sodium channel isoforms and mitogen-activated protein kinases are present in painful human neuromas. Ann Neurol 2008, 64:644-653.
26. Siqueira SR, Alves B, Malpartida HM, Teixeira MJ, Siqueira JT Abnormal expression of voltage-gated sodium channels Nav1.7, Nav1.3 and Nav1.8 in trigeminal neuralgia. Neuroscience 2009, 164:573-577.
27. Hains BC, Waxman SG Sodium channel expression and the molecular pathophysiology of pain after SCI. Prog Brain Res 2007, 161:195-203.
28. Dib-Hajj SD, Black JA, Waxman SG Voltage-gated sodium channels: therapeutic targets for pain. Pain Med 2009, 10:1260-1269.
29. Orstavik K, Weidner C, Schmidt R, et al. Pathological C-fibres in patients with a chronic painful condition. Brain 2003, 126:567-578.
30. Bahia PK, Suzuki R, Benton DC, et al. A functional role for small-conductance calcium-activated potassium channels in sensory pathways including nociceptive processes. J Neurosci 2005, 25:3489-3498.
31. Caterina MJ, Julius D The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001, 24:487-517.
32. Ma W, Zhang Y, Bantel C, Eisenach JC Medium and large injured dorsal root ganglion cells increase TRPV-1, accompanied by increased alpha2C-adrenoceptor co-expression and functional inhibition by clonidine. Pain 2005, 113:386-394.
33. Fischer MJ, Reeh PW Sensitization to heat through G-protein-coupled receptor pathways in the isolated sciatic mouse nerve. Eur J Neurosci 2007, 25:3570-3575.
34. Biggs JE, Yates JM, Loescher AR, Clayton NM, Robinson PP, Boissonade FM Effect of SB-750364, a specific TRPV1 receptor antagonist, on injury-induced ectopic discharge in the lingual nerve. Neurosci Lett 2008, 443:41-45.
35. Serra J, Sola R, Quiles C, et al. C-nociceptors sensitized to cold in a patient with small-fiber neuropathy and cold allodynia. Pain 2009, 147:46-53.
36. Wasner G, Schattschneider J, Binder A, Baron R Topical menthol-a human model for cold pain by activation and sensitization of C nociceptors. Brain 2004, 127:1159-1171.
37. Ultenius C, Linderoth B, Meyerson BA, Wallin J Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat. Neurosci Lett 2006, 399:85-90.
38. Hains BC, Saab CY, Klein JP, Craner MJ, Waxman SG Altered sodium channel expression in second-order spinal sensory neurons contributes to pain after peripheral nerve injury. J Neurosci 2004, 24:4832-4839.
39. Finnerup NB, Jensen TS Spinal cord injury pain-mechanisms and treatment. Eur J Neurol 2004, 11:73-82.
40. Ducreux D, Attal N, Parker F, Bouhassira D Mechanisms of central neuropathic pain: a combined psychophysical and fMRI study in syringomyelia. Brain 2006, 128:963-976.
41. Wasner G, Lee BB, Engel S, McLachlan E Residual spinothalamic tract pathways predict development of central pain after spinal cord injury. Brain 2008, 131:2387-2400.
42. Scholz J, Woolf CJ The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007, 10:1361-1368.
43. Saab CY, Waxman SG, Hains BC Alarm or curse? The pain of neuroinflammation. Brain Res Rev 2008, 58:226-235.
44. Milligan ED, Watkins LR Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 2009, 10:23-36.
45. Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 2002, 22:6724-6731.
46. Scholz J, Broom DC, Youn DH, et al. Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury. J Neurosci 2005, 25:7317-7323.
47. Craig AD How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci 2002, 3:655-666.
48. Raja S, Abatzis V, Frank SM Role of alpha-adrenoreceptors in neuroma pain in amputees. Anesthesiology 1998, 89:A 1083.
49. Choi B, Rowbotham MC Effect of adrenergic receptor activation on post-herpetic neuralgia pain and sensory disturbances. Pain 1997, 69:55-63.
50. Ali Z, Raja SN, Wesselmann U, Fuchs P, Meyer RA, Campbell JN Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain 2000, 88:161-168.
51. Baron R, Schattschneider J, Binder A, Siebrecht D, Wasner G Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: a case-control study. Lancet 2002, 359:1655-1660.
52. McLachlan EM, Jänig W, Devor M, Michaelis M Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature 1993, 363:543-546.
53. Price DD, Long S, Wilsey B, Rafii A Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional syndrome patients. Clin J Pain 1998, 14:216-226.
54. Arning K, Baron R Evaluation of symptom heterogeneity in neuropathic pain using assessments of sensory functions. Neurotherapeutics 2009, 6:738-748.
55. Rolke R, Baron R, Maier C, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 2006, 123:231-243.
56. Baron R, Tolle TR, Gockel U, Brosz M, Freynhagen R A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms. Pain 2009, 146:34-40.
57. Rowbotham MC, Petersen KL Zoster-associated pain and neural dysfunction. Pain 2001, 93:1-5.
58. Oerlemans HM, Oostendorp RA, de Boo T, van der Laan L, Severens JL, Goris JA Adjuvant physical therapy versus occupational therapy in patients with reflex sympathetic dystrophy/complex regional pain syndrome type I. Arch Phys Med Rehabil 2000, 81:49-56.
59. Moseley GL Graded motor imagery for pathologic pain: a randomized controlled trial. Neurology 2006, 67:2129-2134.
60. Ramachandran VS, Altschuler EL The use of visual feedback, in particular mirror visual feedback, in restoring brain function. Brain 2009, 132:1693-1710.
61. Moulin DE, Clark AJ, Gilron I, et al. Pharmacological management of chronic neuropathic pain-consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 2007, 12:13-21.
62. Cruccu G, Gronseth G, Alksne J, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008, 15:1013-1028.
63. Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008, 71:1183-1190.
64. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005, 118:289-305.
65. Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007, 132:237-251.
66. Jensen TS, Madsen CS, Finnerup NB Pharmacology and treatment of neuropathic pains. Curr Opin Neurol 2009, 22:467-474.
67. O'Connor AB, Dworkin RH Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 2009, 122:S22-S32.
68. Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010, 85:S3-14.
69. Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment on neuropathic pain: 2009 revision. Eur J Neurol 2010, published online April 9. 10.1111/j.1468-1331.2010.02999.x.
70. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005, 352:2271-2284.
71. Norrbrink C, Lundeberg T Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial. Clin J Pain 2009, 25:177-184.
72. Raja SN, Haythornthwaite JA, Pappagallo M, et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 2002, 59:1015-1021.
73. Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Curr Med Res Opin 2009, 25:1663-1676.
74. Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy. Curr Med Res Opin 2009, 25:1677-1687.
75. Vilholm OJ, Cold S, Rasmussen L, Sindrup SH Effect of levetiracetam on the postmastectomy pain syndrome. Eur J Neurol 2008, 15:851-857.
76. Finnerup NB, Grydehoj J, Bing J, et al. Levetiracetam in spinal cord injury pain: a randomized controlled trial. Spinal Cord 2009, 47:861-867.
77. Otto M, Bach FW, Jensen TS, Brosen K, Sindrup SH Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, crossover trial. Pain 2008, 139:275-283.
78. Backonja M, Wallace MS, Blonsky ER, et al. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol 2008, 7:1106-1112.
79. Simpson DM, Brown S, Tobias J Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 2008, 70:2305-2313.
80. Ranoux D, Attal N, Morain F, Bouhassira D Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain. Ann Neurol 2008, 64:274-283.
81. Yuan RY, Sheu JJ, Yu JM, et al. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial. Neurology 2009, 72:1473-1478.
82. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med 2005, 352:1324-1334.
83. Hanna M, O'Brien C, Wilson MC Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008, 12:804-813.
84. Gilron I, Bailey JM, Tu D, Holden RR, Jackson AC, Houlden RL Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial. Lancet 2009, 374:1252-1261.
85. Schmader KE, Baron R, Haanpaa ML, et al. Treatment considerations for elderly and frail patients with neuropathic pain. Mayo Clin Proc 2010, 85:S26-S32.
86. Cruccu G, Aziz TZ, Garcia-Larrea L, et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurol 2007, 14:952-970.
87. Dubinsky RM, Miyasak J Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2010, 74:173-176.
88. Binder A, Baron R Utility of transcutaneous electrical nerve stimulation in neurologic pain disorders. Neurology 2010, 74:104-105.
89. Foulkes T, Wood JN Pain genes. PLoS Genet 2008, 4:e1000086.